What are the complications of transurethral resection of bladder tumor (TURBT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Complications of TURBT

TURBT carries a 5-23% overall complication rate, with bleeding (2.8-14.1%) and bladder perforation (1.3-4.7%) being the most common, while the majority (approximately 90%) are low-grade complications (Clavien-Dindo Grade 1-2) that can be managed conservatively. 1, 2

Major Complications

Bleeding

  • Most common complication, occurring in 2.8-14.1% of cases 1, 3
  • Leads to repeat procedures in 84% of bleeding-related complications 3
  • Blood transfusion required in approximately 3.4% of cases 3
  • Strongest predictor: tumor stage, with higher-stage disease significantly increasing bleeding risk 1

Bladder Perforation

  • Occurs in 1.3-4.7% of cases 1, 3
  • Distribution: 83% extraperitoneal, 17% intraperitoneal 3
  • Management: 89% managed conservatively, only 11% require open surgical repair 3
  • Key predictors: presence of detrusor muscle in specimen and resident surgeon performing the procedure 1
  • Important note: Current evidence shows minimal risk of extravesical tumor seeding with conservative management 3

Infectious Complications

  • Urinary tract infections are common postoperative events 4
  • Rare but severe: Septic complications including septic pulmonary embolism have been reported, particularly when bladder perforation occurs with immediate intravesical chemotherapy 5
  • Sepsis incidence varies with operative time, with procedures >90 minutes showing significantly higher rates 6

Catheter-Related Complications

  • Bladder spasms and catheter-related symptoms are frequent 7
  • Contribute to patient discomfort but typically low-grade

High-Grade Complications (Clavien-Dindo Grade 3-5)

Occur in approximately 3.3-10% of cases 1, 2:

  • Grade 3 complications: 3.3-6.4% (requiring surgical intervention)
  • Grade 4 complications: 3.0% (life-threatening)
  • Grade 5 (mortality): 0.1-0.6% 2

Risk Factors for Complications

Patient-Related Factors

  • Age >60-75 years: significantly increases complication risk 2, 6
  • ASA score 3-4: OR 2.075 for complications 4
  • Nicotine use: significant predictor of high-grade complications 1
  • Preoperative hospital stay ≥5 days: OR 3.76 6
  • Preoperative bacteriuria or pyuria: OR 2.97 and 2.54 respectively 6
  • Past pelvic radiotherapy: OR 6.00 6
  • Baseline creatinine >1.4 mg/dL: associated with higher complication rates 2

Tumor-Related Factors

  • Tumor size >4 cm: significantly increases complications 2, 4
  • Tumor multiplicity: OR 1.878 for complications 4
  • High-grade tumors: significant predictor of complications 1
  • Dome location: higher complication rates 2
  • pT2 stage: OR 3.188 for complications 4
  • Carcinoma in situ (CIS): OR 3.476 for complications 4

Operative Factors

  • Resection time >40-60 minutes: progressively increases UTI and sepsis risk 6, 2
    • 30-60 min: OR 1.6 for UTI
    • 60-90 min: OR 1.7 for UTI
    • 90 min: OR 1.9 for UTI and OR 4.6 for sepsis 6

  • Incomplete resection: OR 2.247 for complications and OR 1.904 for prolonged hospital stay 4
  • Resident surgeon: significant predictor of bladder perforation 1, 2

Rare but Serious Complications

  • Ureteral orifice injury: seldom but requires immediate treatment 7, 8
  • Positional nerve damage: rare but can be severe 7
  • Pancytopenia: extremely rare, associated with bladder perforation and immediate intravesical mitomycin C instillation 5
  • TUR syndrome: not specifically mentioned in recent literature but remains a recognized risk

Clinical Implications

The 2026 EAU Guidelines mandate documentation of all complications in the TURBT operative record 9, emphasizing:

  • Systematic performance of individual procedural steps
  • Bimanual palpation before and after resection to detect perforation
  • Avoidance of excessive cauterization to minimize tissue damage
  • Complete documentation of extent and completeness of resection

Outpatient TURBT Considerations

Recent data shows outpatient TURBT has an 8% conversion rate to inpatient care and 11% overall complication rate 10. Predictors of outpatient failure include:

  • Specimen weight ≥1 g (OR 4.35)
  • Longer surgery duration
  • Antiplatelet therapy 10

Impact on Subsequent Radical Cystectomy

Patients with prior maximal TURBT, especially within 1-3 months before radical cystectomy, face increased perioperative complications 11, including higher rates of Clavien-Dindo ≥3 complications (15.3% vs 7.3%), sepsis, and urinary complications.

Key Pitfalls to Avoid

  • Do not routinely use antimicrobial prophylaxis beyond standard perioperative dosing, as evidence shows no significant reduction in symptomatic UTI 6
  • Conservative management is appropriate for most bladder perforations; avoid unnecessary open surgical intervention 3
  • Defer immediate intravesical chemotherapy if bladder perforation is suspected to avoid severe systemic complications 5
  • Ensure adequate surgical experience for complex cases, as resident surgeons have higher perforation rates 1

References

Research

Grading of complications of transurethral resection of bladder tumor using Clavien-Dindo classification system.

Indian journal of urology : IJU : journal of the Urological Society of India, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.